Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer
We conclude that this short but intensive regimen provides worthwhile response rates, even in those patients who would ordinarily be considered refractory to platinum, and has an acceptable toxicity profile.
1705-1709
Meyer, T.
8ac918a9-e659-4d8e-8ada-7c0b205b54e6
Nelstrop, A.E.
6bbdffea-685f-40b9-bf86-e6bce683fde0
Mahmoudi, M.
1dfae087-fe15-4e03-9f1a-510a4a84a6d5
Rustin, G.J.
6a670dea-00b6-4b57-9ca4-c4f3c45eaf3c
December 2001
Meyer, T.
8ac918a9-e659-4d8e-8ada-7c0b205b54e6
Nelstrop, A.E.
6bbdffea-685f-40b9-bf86-e6bce683fde0
Mahmoudi, M.
1dfae087-fe15-4e03-9f1a-510a4a84a6d5
Rustin, G.J.
6a670dea-00b6-4b57-9ca4-c4f3c45eaf3c
Meyer, T., Nelstrop, A.E., Mahmoudi, M. and Rustin, G.J.
(2001)
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer.
Annals of Oncology, 12 (12), .
(PMID:11843248)
Abstract
We conclude that this short but intensive regimen provides worthwhile response rates, even in those patients who would ordinarily be considered refractory to platinum, and has an acceptable toxicity profile.
This record has no associated files available for download.
More information
Accepted/In Press date: 25 July 2001
Published date: December 2001
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 396166
URI: http://eprints.soton.ac.uk/id/eprint/396166
ISSN: 1569-8041
PURE UUID: 92ce53df-e69e-4be3-b242-152fdff1bfac
Catalogue record
Date deposited: 15 Jul 2016 15:46
Last modified: 22 Jul 2022 19:57
Export record
Contributors
Author:
T. Meyer
Author:
A.E. Nelstrop
Author:
M. Mahmoudi
Author:
G.J. Rustin
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics